Treclin® Gel is supplied by our clinic exclusively for the treatment of diagnosed acne vulgaris, specifically when comedones, papules, and pustules are present. If you have any other medical conditions, please consult your GP for an assessment and a prescription. If you already have a prescription, you can send it to us for dispensing.

Treclin® Gel combines clindamycin, an antibiotic that targets acne-causing bacteria, with tretinoin, which helps to unclog pores and prevent the formation of new comedones. This treatment is effective in reducing acne symptoms and promoting clearer skin.

What are the Service Inclusion Criteria?
Treclin® is suitable for a specific group of individuals who meet the following criteria:

• Age Range: 12 to 65 years old.
• Acne Diagnosis: Individuals diagnosed with acne vulgaris presenting comedones, papules, and pustules.
• No Complicating Factors: Suitable for those without complicating skin conditions or history of skin cancer.

Patient Information Leaflet.

Your treatment will be supplied under a Patient Group Direction (PGD), not a traditional prescription. The process includes the following steps:

1. Complete an online health questionnaire

Provide information about your acne symptoms, medical history, and previous treatments.

2. Pharmacist assessment

A pharmacist authorised under this PGD will review your responses and may contact you by phone or video call to confirm eligibility.

3. Private consultation

All consultations are confidential, allowing you to ask questions and confirm that Treclin is suitable for you.

4. All-inclusive pricing

The consultation fee is included in the total price. No hidden costs.

5. Identity verification

First-time patients will be asked to verify their identity to ensure safe and appropriate supply.

6. GP or record consent if required

If clarification is needed, consent to contact your GP or review your medical records may be requested.

Purchasing this medication does not guarantee supply. Final suitability will be determined during the pharmacist consultation under the PGD. If deemed unsuitable, your order will be refunded.

• Active Ingredients:
  • Clindamycin phosphate (1% w/w)
  • Tretinoin (0.025% w/w)
• Excipients:
  • Purified water
  • Glycerol
  • Carbomers
  • Methyl parahydroxybenzoate (E218)
  • Propyl parahydroxybenzoate (E216)
  • Polysorbate 80
  • Disodium edetate
  • Citric acid, anhydrous
  • Butylhydroxytoluene (E321)
  • Trometamol

Treclin® Gel should be applied once daily at night, to clean and dry skin. A small pea-sized amount should be applied to the entire face, avoiding sensitive areas such as the eyes, lips, and nostrils. The gel should be gently rubbed into the skin until it is absorbed. It is important to wash hands thoroughly after application. Treclin® Gel is intended for a maximum treatment period of 12 weeks, after which treatment should be reassessed. If therapeutic improvement is not observed within this period, consult a doctor.

• Treclin® increases susceptibility to UV radiation; minimize sun exposure and avoid sunbeds during treatment.
  • Use a high SPF sunscreen (≥30) and protective clothing when outdoors.
  • If significant irritation or allergic reaction occurs, discontinue use and consult a healthcare professional.
  • Patients with hepatic or renal impairment should use Treclin® with caution due to the potential for increased systemic absorption.

Contraindications

• Hypersensitivity to clindamycin, tretinoin, lincomycin, or any of the excipients listed.
  • Not suitable for use in patients under 12 or over 65 years of age.
  • Do not use if pregnant, breastfeeding, or planning to become pregnant.
  • Avoid in patients with a history of regional enteritis (Crohn's Disease), ulcerative colitis, or antibiotic-associated colitis.
  • Not recommended for patients with acute eczemas, rosacea, perioral dermatitis, or those with a history of skin cancer.
  • Do not apply to sunburned skin or areas that have recently undergone dermatological procedures such as chemical peels or laser resurfacing.
  • Avoid concurrent use with other topical acne treatments or products containing keratolytic agents.

• Common Side Effects:
  • Skin irritation, including redness, dryness, and peeling
  • Burning sensation at the application site
  • Photosensitivity (increased sensitivity to sunlight)
• Uncommon Side Effects:
  • Application site dermatitis
  • Application site discoloration
  • Exacerbation of acne
• Rare Side Effects:
  • Hypersensitivity reactions
  • Gastrointestinal disturbances (nausea, abdominal pain)
  • Headaches

If you experience severe side effects or if symptoms persist, discontinue use and consult your GP or a healthcare professional. Report any adverse effects via the MHRA Yellow Card scheme.

For more information, please refer to the Patient Information Leaflet.